Search results for "dementia treatment"

GemVax’s GV1001 Activates Brain’s 'Cleanup Cells' to Clear Alzheimer’s Plaques

GemVax’s GV1001 Activates Brain’s 'Cleanup Cells' to Clear Alzheimer’s Plaques

GemVax & Kael announced on June 10 that a study detailing the therapeutic mechanism of its Alzheimer’s disease drug candidate, GV1001, has been...
New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment

New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment

Dementia medications do not yield uniform results for every patient; instead, their clinical efficacy depends heavily on a distinct "optimal...
Can 'Sound and Light' Treat the Brain? New Hope for Dementia Therapy Without Side Effects

Can 'Sound and Light' Treat the Brain? New Hope for Dementia Therapy Without Side Effects

A South Korean research team has demonstrated the potential for treating Alzheimer’s disease using non-invasive sound...
Beyond Facial Wrinkles: 5 Internal Factors Accelerating Biological Aging

Beyond Facial Wrinkles: 5 Internal Factors Accelerating Biological Aging

Aging is an inevitable biological process, but the rate at which it occurs is largely within individual control.
Mild Cognitive Impairment Doesn’t Always Lead to Dementia—Early Diagnosis and Lifestyle Management Are Key

Mild Cognitive Impairment Doesn’t Always Lead to Dementia—Early Diagnosis and Lifestyle Management Are Key

Sept. 21 marks Dementia Overcoming Day, a designated observance created to raise public awareness about preventing and...
When You Can’t Recall

When You Can’t Recall "Madeleine": Short Film Youngsikxty Spotlights Early Dementia Awareness

“Less ice in the oat latte… and, you know, that thing. What is it, the yellow round thing.
Do Wegovy and Mounjaro Count as Doping? WADA Monitors GLP-1 Drugs in Sports

Do Wegovy and Mounjaro Count as Doping? WADA Monitors GLP-1 Drugs in Sports

GLP-1 (glucagon-like peptide-1) class medications, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, are...
Taking Leqembi Isn’t Enough: Only 3% of Early Alzheimer’s Patients Follow Recommended Lifestyle Habits

Taking Leqembi Isn’t Enough: Only 3% of Early Alzheimer’s Patients Follow Recommended Lifestyle Habits

The arrival of disease-modifying treatments capable of slowing Alzheimer’s progression has offered patients newfound...
Two-Hour Visit, Endless 'Do You Recognize Me?': Why Nursing Home Visits Need Purpose, Not Interrogation

Two-Hour Visit, Endless 'Do You Recognize Me?': Why Nursing Home Visits Need Purpose, Not Interrogation

"Some family members still view moving a parent into a facility as a modern-day Goryeojang [a traditional myth of...
'2 Million Brain Cells Die Every Minute': Neurologists Call for National Strategy as South Korea Ages

'2 Million Brain Cells Die Every Minute': Neurologists Call for National Strategy as South Korea Ages

"In a super-aged society, brain diseases represent a core healthcare challenge that the nation must tackle...